📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
40
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
🔄 Reverse Split
55%
• 50-day avg $0.90 below $1 exchange minimum
📜 Warrant Exercise
15%
• Warrant overhang: 13.3% of shares outstanding
💹 Market Data
Market Cap$7.00M
Shares Outstanding9.93M
FloatN/A
Cash$59.26M
Debt$2.06M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 25.3% shares (2025Q4 vs prior)
39 institutional holders · 8.80M shares
#1
Avidity Partners Management LP
2.08M shares
#2
GOLDMAN SACHS GROUP INC
1.98M shares
#3
VANGUARD GROUP INC
1.76M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.27M
Days to Cover6.4
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
S-3
SHELF
May 01, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
8-K
8K EVENT
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SCYX
📊 SCYX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SCYX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.